Articles

Studies highlight the need for specialists and training programs focusing on the disease.

Why uveitis is a leading and underestimated cause of visual morbidity in patients

Cheryl Guttman is a medical writer based in Deerfield, Ill.

Technology helps physicians understand normal and abnormal macular anatomy

How ophthalmologists can benefit from en face OCT

Key is to recognize usual patterns for systemic and topical medications

Medication-induced retinal toxicity: How risk awareness can help

Transient sensory-motor abnormalities are often common

Strategies for managing strabismus after repair of retinal detachments

Videos

Anat Loewenstein, MD, MHA, discusses data from the Angiogenesis, Exudation, and Degeneration 2021 Virtual Symposium on angiopoietin-2/VEGF-A dual inhibition in the management of diabetic macular edema and exudative age-related macular degeneration.

Rapid Readout: Angiopoietin-2 (Ang2) Inhibition in the Treatment of Diabetic Macular Edema and Exudative AMD.

Injections and implants continue to create further positive outcomes for patients.

Novel options continue to fill  sustained drug delivery pipeline 

Cheryl Guttman Krader is a contributor to Dermatology Times, Ophthalmology Times, and Urology Times.

Novel option demonstrates stable to improved visual acuity and retinal thickness

Subretinal gene therapy for neovascular AMD showing efficacy and safety 

Studying zebrafish helps unravel mysteries of photoreceptor regeneration

Inherited retinal dystrophies: How regeneration may help restore vision

Short FLIO flecks may appear before changes are seen on other imaging modalities, including OCT. 

Casting a new light on fundus imaging

This novel intravitreal gene therapy may also hold potential for the treatment of diabetic macular edema.

Inherited retinal dystrophies: How regeneration may help restore vision

Casting a new light on fundus imaging

ADVM-022: Sustained anatomic improvements for wet AMD